Cargando…
A novel approach to target hypoxic cancer cells via combining β-oxidation inhibitor etomoxir with radiation
BACKGROUND: Hypoxia in tumors is associated with resistance towards various therapies including radiotherapy. In this study, we assessed if hypoxia in cancer spheres could be effectively reduced by adding etomoxir (a β-oxidation inhibitor) immediately after cell irradiation. METHODS: We employed can...
Autores principales: | Dheeraj, Arpit, Agarwal, Chapla, Schlaepfer, Isabel R, Raben, David, Singh, Rana, Agarwal, Rajesh, Deep, Gagan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109663/ https://www.ncbi.nlm.nih.gov/pubmed/30175155 http://dx.doi.org/10.2147/HP.S163115 |
Ejemplares similares
-
Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1
por: Nambiar, Dhanya K., et al.
Publicado: (2014) -
Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation
por: Schlaepfer, Isabel R., et al.
Publicado: (2015) -
Asiatic Acid Inhibits Pro-Angiogenic Effects of VEGF and Human Gliomas in Endothelial Cell Culture Models
por: Kavitha, Chandagirikoppal V., et al.
Publicado: (2011) -
Silibinin enhances the repair of ultraviolet B-induced DNA damage by activating p53-dependent nucleotide excision repair mechanism in human dermal fibroblasts
por: Guillermo-Lagae, Ruth, et al.
Publicado: (2015) -
The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations
por: O’Connor, Roddy S., et al.
Publicado: (2018)